
Femtech changed fertility. Now it's ready to rebuild maternal health
In the past decade, femtech has emerged as an industry helping women manage a range of health challenges. Maternal health, however, hasn't received nearly the attention it deserves. There is a pressing need for innovation across prenatal, labor and delivery and postpartum care. The United States' maternal mortality rate is still 18.6 deaths per 100,000 live births.Other maternal health and delivery complications, while not fatal, may impact women's cardiovascular, pelvic, and mental health for the rest of their lives.
It's instructive to look at the fertility market to see just how much we could improve maternal health with a concerted effort by technologists, entrepreneurs, and investors. Fertility solutions have received the most investment across femtech, with over $10 billion in venture and private equity investment in the past decade. Every aspect of fertility has received significant investment, from employer-based benefits programs to cycle-tracking apps and wearables, to at-home fertility and insemination kits, plus a range of high-tech solutions for fertility clinics. This investment of capital has led to meaningful gains: At-home kits are reducing costs for individuals, AI is improving IVF outcomes, and employer-backed benefits are expanding access to care.
We need the same attention and investment focused on maternal health. Here are three places to start:
1. REAL-TIME PREGNANCY MONITORING AND SCREENING
With more maternal health deserts occurring in the US and abroad, remote monitoring may help fill the gap to detect complications before they escalate. Femtech startups are developing robust wearable technology, including smart rings and adhesive sensors designed to track fetal movement, as well as connected devices for early detection of preeclampsia and gestational diabetes.
Bloomful recently earned FDA clearance for a device that tracks blood pressure, glucose levels, and fetal heart rate. Their system has demonstrated significant improvements in maternal health outcomes, including a 61% reduction in preeclampsia cases among high-risk pregnancies.
Another promising development is Armor Medical's wearable to proactively detect postpartum hemorrhage. The company has developed a wrist sensor that provides objective, real-time insights on blood loss for early intervention.
While wearables are one way to monitor pregnancy and detect early complications, biomarkers offer another option. For example, Dionysus Health has created an epigenetic test to prescreen for postpartum depression in the third trimester. And MOMM Diagnostics is pioneering a simple finger-stick kit to be used at home that detects preeclampsia biomarkers well before symptoms arise.
The critical challenge is making maternal monitoring and screening tech scalable, affordable, and accessible to all expectant mothers, and building the systems necessary to monitor and respond to the issues surfaced.
2. PRETERM LABOR DETECTION AND PREVENTION
10% of all babies in the US are born preterm, often ending up in intensive care and facing more health issues over time. These babies may struggle with feeding and immune system development, while preterm mothers are at greater risk for postpartum bleeding and infection, postpartum depression and challenges with breastfeeding.
Although the technology is still in its early stages, promising tools are available to help detect and prevent preterm labor. Pregonlia is developing a medtech device to detect early signs of preterm labor, and Stanford is using health data from wearables plus AI to identify disrupted circadian rhythms, which may indicate an increased risk of pre-term labor. In the future, new devices like Novocuff can help close the cervix to retain amniotic fluid and maintain cervical length, thereby preventing early delivery.
Preterm labor technology is still in its infancy, but with increased investment and careful integration into clinical workflows, these tools have the potential to make a meaningful impact.
3. POSTPARTUM CARE
Many women experience physical and mental health issues after they leave the hospital. Yet, in most cases, the postpartum care plan consists of a follow-up appointment six weeks after delivery. It is no surprise that complications are often missed and mental health conditions go untreated.
Femtech can provide continuous care, and a wave of new tools is emerging to help close this gap. Some offer continuous physical recovery tracking, while others integrate mental health screening and virtual access to doulas, pelvic floor specialists, and lactation support. The opportunity in this space is huge, and many fertility-focused companies, like Maven and Progyny, now offer wrap-around care to support families through the first year, understanding the benefits afforded to the mothers as well as employers.
The solutions moving forward need both better research and broader reach, which can only be achieved through continued innovation, increased investment in research and technology, and policy change.
WHERE CHANGE IS NEEDED
Healthcare transformation moves slowly. Shifting the standard of care requires clear clinical evidence, upfront investment, and coordination across the system. New models must demonstrate real-world outcomes, fit into existing workflows, and be reimbursable to even have a chance at successful adoption.
Change will be driven by two factors: investment and employers. Specialized funds like Wellstar Catalyst, the Laerdal Million Lives Fund, and Medicines360's Innovation Hub are stepping up investment in maternal health innovation. More investment is needed from VCs and private equity to fund maternal care innovation at scale. At the same time, employers have a unique opportunity to accelerate this transformation using the same playbook that worked for fertility and family building benefits. By supporting new mothers through comprehensive care, companies can improve retention with better support for their employees.
We've already proven that focused investment and innovation can transform women's healthcare. Femtech changed everything for conception and family building. Now, maternal health is ready for the same revolution. It's time to rebuild birth and the first year.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
14 minutes ago
- CBS News
Maryland therapist worries less LGTBQ+ youth will seek help with 988 changes in effect
It's been nearly two weeks since the 988 dedicated lifeline for LGBTQ+ youth discontinued, and a Maryland therapist is worried about the long-term impact this will have. When the Trump administration announced in June that the 988 Suicide and Crisis Lifeline dedicated to these youth would end, advocates warned it would have life-threatening implications. It was better known as the Press 3 option. For at least one therapist, she said the impacts could lead to these youth hesitating to get help. The Substance Abuse and Mental Health Services Administration, or SAMHSA, said the 988's dedicated LGBTQ+ youth lifeline ended because the funding for it had been exhausted. The agency stressed these youth would still be able to get help if they still called 988. However, Xiomara Arrieta, a therapist with ThriveWorks, said she heard these youth feel like they're losing representation in this support. "Some people don't have that availability of people in the community who they can look up living their truth," Arrieta said. Arrieta adds that losing the lifeline takes away the ability for these youth to talk to someone who may fully understand their problems. "With the way gender is affirmed or not important for people to kind of come in and get it — as opposed to explaining the genre or how someone is presenting and why they are," Arrieta said. Earlier this month, WJZ reported local advocates were preparing to step up to fill the gap. One of them is the Pride Center of Maryland. Its CEO, Cleo Manago, said he wasn't surprised when he first heard about this lifeline ending. In response, Manago said they were bolstering youth programming and other suicide prevention resources, as well as creating a suicide warm line. "[A suicide warm line] means that there'll be live people to speak to about any suicide concerns or ideations [during traditional work hours]," Manago said. "For the rest of the time, there will be a recording that will alert people where they can call, where they can go." Behavioral Health System Baltimore stressed that the Central Maryland 988 helpline is still going to provide dedicated support for LGBTQ+ youth. The 988 Central Maryland helpline gets about 4,500 calls a month.


Washington Post
3 hours ago
- Washington Post
NIH cuts spotlight a hidden crisis facing patients with experimental brain implants
Carol Seeger finally escaped her debilitating depression with an experimental treatment that placed electrodes in her brain and a pacemaker-like device in her chest. But when its batteries stopped working, insurance wouldn't pay to fix the problem and she sank back into a dangerous darkness. She worried for her life, asking herself: 'Why am I putting myself through this?'
Yahoo
5 hours ago
- Yahoo
UnitedHealth Group's (UNH) Healthcare Dominance: A Key Player in the Dogs of the Dow
UnitedHealth Group Incorporated (NYSE:UNH) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A senior healthcare professional giving advice to a patient in a clinic. The stock has dropped over 44% so far this year after reporting weaker-than-expected earnings in the first quarter. The company first reduced its full-year outlook and later chose to withdraw it entirely. Even with the underwhelming Q1 performance, UnitedHealth Group Incorporated (NYSE:UNH) still posted a 9.8% year-over-year increase in revenue, reaching $109.6 billion. It earned a profit of around $6.3 billion during the quarter and maintained a solid financial position, holding close to $34.3 billion in cash and cash equivalents, along with a debt level that remains manageable. The company has added 780,000 new members so far this year. Meanwhile, Optum Health still expects to provide value-based care to an additional 650,000 patients in 2025. In addition, UnitedHealth Group Incorporated (NYSE:UNH) generated $5.5 billion in operating cash flow during the quarter and returned $5 billion to investors through dividends and share repurchases. The company has been rewarding shareholders with growing dividends since 2011 and currently offers a quarterly dividend of $2.21 per share. The stock supports a dividend yield of 3.15%, as of July 26. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data